KNSA compared with HRTX: revenue, margins and what each company keeps, and the suppliers and customers both name

KNSAKiniksa Pharmaceuticals International, plc

Mkt capRevenueRevenue

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

KNSAKiniksa Pharmaceuticals International, plc

HRTXHeron Therapeutics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

KNSAwithHRTX

No shared trading history for KNSA and HRTX.

Shared co-movers: not yet measured (KNSA).

KNSA, solidHRTX, hatchedr = correlationBar = r to r 0.75Source: daily closes

KNSAKiniksa Pharmaceuticals International, plc

90.92· pre 92.49· delayed

Mkt cap$7.2BRevenue$286MQ3 FY26Revenue$678MFY25

HRTXHeron Therapeutics, Inc.

0.28· pre 0.30· delayed

Pre-marketNov 3 '26delayed

Mkt cap$56.0MRevenue$38MQ2 FY26Revenue$155MFY25

Compare

Pre-marketNov 3 '26delayed

KNSAKiniksa Pharmaceuticals International, plc

HRTXHeron Therapeutics, Inc.

90.92pre 92.49delayed

Price

0.28pre 0.30delayed

$7.2B

Mkt cap

$56.0M

Q3 FY26$286M

Revenue

$38MQ2 FY26

FY25$678M

Revenue

$155MFY25

KNSA90.92vsHRTX0.28Pre-marketNov 3 '26delayed